Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,882 | -26,466 | -12,620 | -53,530 | -39,084 |
| Depreciation Amortization | 301 | 225 | 105 | 430 | 198 |
| Accounts receivable | -3 | 22 | -86 | 455 | -6,522 |
| Accounts payable and accrued liabilities | -2,007 | -313 | -1,245 | 1,485 | 1,277 |
| Other Working Capital | -4,040 | 1,948 | -913 | 8,077 | 620 |
| Other Operating Activity | 8,611 | 4,743 | 3,578 | 7,343 | 12,152 |
| Operating Cash Flow | $-37,020 | $-19,841 | $-11,181 | $-35,740 | $-31,359 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,036 | 16,002 | 1 | -62,288 | -42,000 |
| PPE Investments | -344 | -261 | -202 | -133 | -76 |
| Investing Cash Flow | $25,692 | $15,741 | $-201 | $-62,421 | $-42,076 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 683 | 397 | 286 | 30,454 | 30,948 |
| Financing Cash Flow | $683 | $397 | $286 | $30,454 | $30,948 |
| Beginning Cash Position | 45,214 | 45,214 | 45,214 | 112,921 | 112,921 |
| End Cash Position | 34,569 | 41,511 | 34,118 | 45,214 | 70,434 |
| Net Cash Flow | $-10,645 | $-3,703 | $-11,096 | $-67,707 | $-42,487 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,020 | -19,841 | -11,181 | -35,740 | -31,359 |
| Capital Expenditure | -344 | -261 | -202 | -133 | -76 |
| Free Cash Flow | -37,364 | -20,102 | -11,383 | -35,873 | -31,435 |